GlaxoSmithKline PLC Chair of Audit & Risk Committee (6312S)
2021年3月18日 - 3:24AM
RNSを含む英国規制内ニュース (英語)
TIDMGSK
RNS Number : 6312S
GlaxoSmithKline PLC
17 March 2021
GlaxoSmithKline plc
(the 'Company')
Chair of Audit & Risk Committee
Mr Charlie Bancroft succeeded Ms Judy Lewent as chair of the
Company's Audit & Risk Committee on 13 March 2021. Ms Lewent
will remain a Non-Executive Director of the Company and member of
the Audit & Risk Committee and the other Board committees on
which she sits until the conclusion of the 2021 Annual General
Meeting due to be held on Wednesday 5 May 2021.
V A Whyte
Company Secretary
17 March 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNJRMPTMTTBBTB
(END) Dow Jones Newswires
March 17, 2021 14:24 ET (18:24 GMT)
Gsk (LSE:GSK)
過去 株価チャート
から 3 2024 まで 4 2024
Gsk (LSE:GSK)
過去 株価チャート
から 4 2023 まで 4 2024